Filter by

Search tool

Displaying 41 - 50 of 86
Document library

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims...
Document library

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions

It is estimated that ca 4.7 million people living in European Union (EU) and European Economic Area (EEA) countries are chronically infected with the hepatitis B virus (HBV) and 5.6 million have...
Document library

Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England

This scientific article was one of the 2018 EMCDDA scientific award winners, which celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs. This article won the award in...
Document library

HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden

In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. NPS injectors in Hungary are at severe risk of blood-borne infections...
Document library

New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe

This scoping study was based on a targeted multi-source data collection exercise focusing on the provision of health and drug interventions associated with NPS use and harms, in selected intervention settings across...
Document library

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

In June 2014 the Athens High Level Meeting discussed recent policy developments, persisting and emerging challenges related to the prevention and management of viral hepatitis and the need for a de minimis...
Paper
Document library

HCV promotional material example: Hepatitis B and C testing: Why? Who? How?

A guidance paper on testing in community and harm reduction settings. The paper includes the key facts about hepatitis B and C; Harm reduction as prevention; key recommendations about awareness raising and...
Leaflet for drug users
Document library

HCV promotional material example: Hepatitis. Das Wichtigste in Kürze

The leaflet contains information about the key facts about hepatitis; the screening technologies and target group; the prevention of hepatitis, and the treatment.
Leaflet for drug users
Document library

HCV promotional material example: Löffel, Filter, Wasser: Konsumutensilien und Hepatitis B/C - Kurzinfos für Drogengebraucher

The leaflet covers information about hepatitis C, B and HIV, and related infection risks. It is a brief information for drug users. It was produced based on the outcomes from the DRUCK...
Document library

Review of European-Drug Emergencies Network (Euro-DEN) training package for non-specialist workers to assess acute recreational drug and new psychoactive substance toxicity in night-time economy environments

The initial management of acute recreational drug and new psychoactive substance (NPS) toxicity is often by non-specialists working in the night-time economy. The aim was as part of the European Drug Emergencies...
Top